nodes	percent_of_prediction	percent_of_DWPC	metapath
Dextropropoxyphene—CYP2C8—Montelukast—chronic obstructive pulmonary disease	0.0803	0.118	CbGbCtD
Dextropropoxyphene—CYP2C9—Arformoterol—chronic obstructive pulmonary disease	0.0739	0.109	CbGbCtD
Dextropropoxyphene—CYP2C9—Formoterol—chronic obstructive pulmonary disease	0.0739	0.109	CbGbCtD
Dextropropoxyphene—CYP2D6—Formoterol—chronic obstructive pulmonary disease	0.0676	0.0993	CbGbCtD
Dextropropoxyphene—CYP2D6—Arformoterol—chronic obstructive pulmonary disease	0.0676	0.0993	CbGbCtD
Dextropropoxyphene—CYP2D6—Tiotropium—chronic obstructive pulmonary disease	0.0602	0.0885	CbGbCtD
Dextropropoxyphene—CYP3A4—Salbutamol—chronic obstructive pulmonary disease	0.0567	0.0833	CbGbCtD
Dextropropoxyphene—CYP2C9—Montelukast—chronic obstructive pulmonary disease	0.056	0.0823	CbGbCtD
Dextropropoxyphene—CYP3A4—Tiotropium—chronic obstructive pulmonary disease	0.0383	0.0563	CbGbCtD
Dextropropoxyphene—CYP3A4—Aminophylline—chronic obstructive pulmonary disease	0.0365	0.0537	CbGbCtD
Dextropropoxyphene—CYP3A4—Montelukast—chronic obstructive pulmonary disease	0.0326	0.0478	CbGbCtD
Dextropropoxyphene—CYP3A4—Prednisolone—chronic obstructive pulmonary disease	0.0191	0.0281	CbGbCtD
Dextropropoxyphene—CYP3A4—Prednisone—chronic obstructive pulmonary disease	0.018	0.0265	CbGbCtD
Dextropropoxyphene—Levomethadyl Acetate—CHRNA3—chronic obstructive pulmonary disease	0.00153	0.227	CrCbGaD
Dextropropoxyphene—Cardiac failure congestive—Formoterol—chronic obstructive pulmonary disease	0.00149	0.00604	CcSEcCtD
Dextropropoxyphene—Cardiac failure congestive—Arformoterol—chronic obstructive pulmonary disease	0.00149	0.00604	CcSEcCtD
Dextropropoxyphene—Myopathy—Prednisolone—chronic obstructive pulmonary disease	0.00144	0.00583	CcSEcCtD
Dextropropoxyphene—Hepatomegaly—Prednisolone—chronic obstructive pulmonary disease	0.00142	0.00578	CcSEcCtD
Dextropropoxyphene—Discomfort—Roflumilast—chronic obstructive pulmonary disease	0.00135	0.00547	CcSEcCtD
Dextropropoxyphene—Nervous system disorder—Roflumilast—chronic obstructive pulmonary disease	0.00128	0.0052	CcSEcCtD
Dextropropoxyphene—Ataxia—Salbutamol—chronic obstructive pulmonary disease	0.0012	0.00487	CcSEcCtD
Dextropropoxyphene—Insomnia—Roflumilast—chronic obstructive pulmonary disease	0.00118	0.0048	CcSEcCtD
Dextropropoxyphene—Dyspepsia—Roflumilast—chronic obstructive pulmonary disease	0.00115	0.00467	CcSEcCtD
Dextropropoxyphene—Gastrointestinal disorder—Roflumilast—chronic obstructive pulmonary disease	0.00113	0.00458	CcSEcCtD
Dextropropoxyphene—Constipation—Roflumilast—chronic obstructive pulmonary disease	0.00112	0.00454	CcSEcCtD
Dextropropoxyphene—Visual impairment—Tiotropium—chronic obstructive pulmonary disease	0.00112	0.00453	CcSEcCtD
Dextropropoxyphene—Arrhythmia—Aminophylline—chronic obstructive pulmonary disease	0.0011	0.00445	CcSEcCtD
Dextropropoxyphene—Quinapril—ACE—chronic obstructive pulmonary disease	0.00109	0.162	CrCbGaD
Dextropropoxyphene—Eye disorder—Tiotropium—chronic obstructive pulmonary disease	0.00108	0.00439	CcSEcCtD
Dextropropoxyphene—Feeling abnormal—Roflumilast—chronic obstructive pulmonary disease	0.00108	0.00437	CcSEcCtD
Dextropropoxyphene—Gastrointestinal pain—Roflumilast—chronic obstructive pulmonary disease	0.00107	0.00434	CcSEcCtD
Dextropropoxyphene—Immune system disorder—Tiotropium—chronic obstructive pulmonary disease	0.00105	0.00424	CcSEcCtD
Dextropropoxyphene—Myopathy—Prednisone—chronic obstructive pulmonary disease	0.00104	0.00424	CcSEcCtD
Dextropropoxyphene—Mediastinal disorder—Tiotropium—chronic obstructive pulmonary disease	0.00104	0.00423	CcSEcCtD
Dextropropoxyphene—Hepatomegaly—Prednisone—chronic obstructive pulmonary disease	0.00103	0.0042	CcSEcCtD
Dextropropoxyphene—Arrhythmia—Tiotropium—chronic obstructive pulmonary disease	0.00103	0.0042	CcSEcCtD
Dextropropoxyphene—Abdominal pain—Roflumilast—chronic obstructive pulmonary disease	0.00103	0.00419	CcSEcCtD
Dextropropoxyphene—Acute coronary syndrome—Arformoterol—chronic obstructive pulmonary disease	0.00103	0.00416	CcSEcCtD
Dextropropoxyphene—Acute coronary syndrome—Formoterol—chronic obstructive pulmonary disease	0.00103	0.00416	CcSEcCtD
Dextropropoxyphene—Myocardial infarction—Formoterol—chronic obstructive pulmonary disease	0.00102	0.00414	CcSEcCtD
Dextropropoxyphene—Myocardial infarction—Arformoterol—chronic obstructive pulmonary disease	0.00102	0.00414	CcSEcCtD
Dextropropoxyphene—Drowsiness—Montelukast—chronic obstructive pulmonary disease	0.00102	0.00414	CcSEcCtD
Dextropropoxyphene—Malnutrition—Tiotropium—chronic obstructive pulmonary disease	0.00101	0.00409	CcSEcCtD
Dextropropoxyphene—Jaundice—Montelukast—chronic obstructive pulmonary disease	0.000994	0.00403	CcSEcCtD
Dextropropoxyphene—Drowsiness—Salbutamol—chronic obstructive pulmonary disease	0.000983	0.00399	CcSEcCtD
Dextropropoxyphene—Agitation—Aminophylline—chronic obstructive pulmonary disease	0.000982	0.00398	CcSEcCtD
Dextropropoxyphene—Hepatobiliary disease—Montelukast—chronic obstructive pulmonary disease	0.000964	0.00391	CcSEcCtD
Dextropropoxyphene—Hypersensitivity—Roflumilast—chronic obstructive pulmonary disease	0.000964	0.00391	CcSEcCtD
Dextropropoxyphene—Jaundice—Salbutamol—chronic obstructive pulmonary disease	0.000958	0.00389	CcSEcCtD
Dextropropoxyphene—Vision blurred—Tiotropium—chronic obstructive pulmonary disease	0.00095	0.00385	CcSEcCtD
Dextropropoxyphene—Asthenia—Roflumilast—chronic obstructive pulmonary disease	0.000939	0.00381	CcSEcCtD
Dextropropoxyphene—Convulsion—Aminophylline—chronic obstructive pulmonary disease	0.000926	0.00376	CcSEcCtD
Dextropropoxyphene—Hallucination—Montelukast—chronic obstructive pulmonary disease	0.000911	0.00369	CcSEcCtD
Dextropropoxyphene—Syncope—Tiotropium—chronic obstructive pulmonary disease	0.000904	0.00367	CcSEcCtD
Dextropropoxyphene—Visual impairment—Formoterol—chronic obstructive pulmonary disease	0.000901	0.00365	CcSEcCtD
Dextropropoxyphene—Visual impairment—Arformoterol—chronic obstructive pulmonary disease	0.000901	0.00365	CcSEcCtD
Dextropropoxyphene—Diarrhoea—Roflumilast—chronic obstructive pulmonary disease	0.000895	0.00363	CcSEcCtD
Dextropropoxyphene—Loss of consciousness—Tiotropium—chronic obstructive pulmonary disease	0.000886	0.00359	CcSEcCtD
Dextropropoxyphene—Cardiac disorder—Formoterol—chronic obstructive pulmonary disease	0.000867	0.00352	CcSEcCtD
Dextropropoxyphene—Cardiac disorder—Arformoterol—chronic obstructive pulmonary disease	0.000867	0.00352	CcSEcCtD
Dextropropoxyphene—Euphoric mood—Prednisolone—chronic obstructive pulmonary disease	0.000866	0.00351	CcSEcCtD
Dextropropoxyphene—Dizziness—Roflumilast—chronic obstructive pulmonary disease	0.000865	0.00351	CcSEcCtD
Dextropropoxyphene—Shock—Aminophylline—chronic obstructive pulmonary disease	0.000858	0.00348	CcSEcCtD
Dextropropoxyphene—Nervous system disorder—Aminophylline—chronic obstructive pulmonary disease	0.000856	0.00347	CcSEcCtD
Dextropropoxyphene—Tachycardia—Aminophylline—chronic obstructive pulmonary disease	0.000851	0.00345	CcSEcCtD
Dextropropoxyphene—Cardiac disorder—Montelukast—chronic obstructive pulmonary disease	0.00085	0.00345	CcSEcCtD
Dextropropoxyphene—Immune system disorder—Arformoterol—chronic obstructive pulmonary disease	0.000844	0.00342	CcSEcCtD
Dextropropoxyphene—Immune system disorder—Formoterol—chronic obstructive pulmonary disease	0.000844	0.00342	CcSEcCtD
Dextropropoxyphene—Mediastinal disorder—Formoterol—chronic obstructive pulmonary disease	0.000842	0.00342	CcSEcCtD
Dextropropoxyphene—Mediastinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.000842	0.00342	CcSEcCtD
Dextropropoxyphene—Arrhythmia—Arformoterol—chronic obstructive pulmonary disease	0.000835	0.00339	CcSEcCtD
Dextropropoxyphene—Arrhythmia—Formoterol—chronic obstructive pulmonary disease	0.000835	0.00339	CcSEcCtD
Dextropropoxyphene—Vomiting—Roflumilast—chronic obstructive pulmonary disease	0.000832	0.00337	CcSEcCtD
Dextropropoxyphene—Immune system disorder—Montelukast—chronic obstructive pulmonary disease	0.000827	0.00335	CcSEcCtD
Dextropropoxyphene—Mediastinal disorder—Montelukast—chronic obstructive pulmonary disease	0.000825	0.00335	CcSEcCtD
Dextropropoxyphene—Rash—Roflumilast—chronic obstructive pulmonary disease	0.000825	0.00335	CcSEcCtD
Dextropropoxyphene—Dermatitis—Roflumilast—chronic obstructive pulmonary disease	0.000824	0.00334	CcSEcCtD
Dextropropoxyphene—Headache—Roflumilast—chronic obstructive pulmonary disease	0.00082	0.00332	CcSEcCtD
Dextropropoxyphene—Cardiac disorder—Salbutamol—chronic obstructive pulmonary disease	0.000819	0.00332	CcSEcCtD
Dextropropoxyphene—Hypotension—Aminophylline—chronic obstructive pulmonary disease	0.000815	0.00331	CcSEcCtD
Dextropropoxyphene—Malnutrition—Arformoterol—chronic obstructive pulmonary disease	0.000814	0.0033	CcSEcCtD
Dextropropoxyphene—Malnutrition—Formoterol—chronic obstructive pulmonary disease	0.000814	0.0033	CcSEcCtD
Dextropropoxyphene—Shock—Tiotropium—chronic obstructive pulmonary disease	0.000809	0.00328	CcSEcCtD
Dextropropoxyphene—Nervous system disorder—Tiotropium—chronic obstructive pulmonary disease	0.000807	0.00327	CcSEcCtD
Dextropropoxyphene—Cardiac failure congestive—Prednisolone—chronic obstructive pulmonary disease	0.000807	0.00327	CcSEcCtD
Dextropropoxyphene—Tachycardia—Tiotropium—chronic obstructive pulmonary disease	0.000803	0.00326	CcSEcCtD
Dextropropoxyphene—Immune system disorder—Salbutamol—chronic obstructive pulmonary disease	0.000797	0.00323	CcSEcCtD
Dextropropoxyphene—Mediastinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.000795	0.00323	CcSEcCtD
Dextropropoxyphene—Insomnia—Aminophylline—chronic obstructive pulmonary disease	0.000789	0.0032	CcSEcCtD
Dextropropoxyphene—Arrhythmia—Salbutamol—chronic obstructive pulmonary disease	0.000788	0.0032	CcSEcCtD
Dextropropoxyphene—Nausea—Roflumilast—chronic obstructive pulmonary disease	0.000777	0.00315	CcSEcCtD
Dextropropoxyphene—Visual disturbance—Prednisolone—chronic obstructive pulmonary disease	0.000772	0.00313	CcSEcCtD
Dextropropoxyphene—Malnutrition—Salbutamol—chronic obstructive pulmonary disease	0.000768	0.00312	CcSEcCtD
Dextropropoxyphene—Dyspepsia—Aminophylline—chronic obstructive pulmonary disease	0.000768	0.00311	CcSEcCtD
Dextropropoxyphene—Agitation—Formoterol—chronic obstructive pulmonary disease	0.000748	0.00303	CcSEcCtD
Dextropropoxyphene—Agitation—Arformoterol—chronic obstructive pulmonary disease	0.000748	0.00303	CcSEcCtD
Dextropropoxyphene—Insomnia—Tiotropium—chronic obstructive pulmonary disease	0.000744	0.00302	CcSEcCtD
Dextropropoxyphene—Agitation—Montelukast—chronic obstructive pulmonary disease	0.000732	0.00297	CcSEcCtD
Dextropropoxyphene—Dyspepsia—Tiotropium—chronic obstructive pulmonary disease	0.000724	0.00294	CcSEcCtD
Dextropropoxyphene—Gastrointestinal pain—Aminophylline—chronic obstructive pulmonary disease	0.000713	0.00289	CcSEcCtD
Dextropropoxyphene—Gastrointestinal disorder—Tiotropium—chronic obstructive pulmonary disease	0.00071	0.00288	CcSEcCtD
Dextropropoxyphene—Agitation—Salbutamol—chronic obstructive pulmonary disease	0.000706	0.00286	CcSEcCtD
Dextropropoxyphene—Constipation—Tiotropium—chronic obstructive pulmonary disease	0.000704	0.00285	CcSEcCtD
Dextropropoxyphene—Cardiac arrest—Prednisolone—chronic obstructive pulmonary disease	0.000696	0.00282	CcSEcCtD
Dextropropoxyphene—Convulsion—Montelukast—chronic obstructive pulmonary disease	0.00069	0.0028	CcSEcCtD
Dextropropoxyphene—Abdominal pain—Aminophylline—chronic obstructive pulmonary disease	0.00069	0.0028	CcSEcCtD
Dextropropoxyphene—Syncope—Salbutamol—chronic obstructive pulmonary disease	0.000689	0.00279	CcSEcCtD
Dextropropoxyphene—Discomfort—Formoterol—chronic obstructive pulmonary disease	0.000684	0.00278	CcSEcCtD
Dextropropoxyphene—Discomfort—Arformoterol—chronic obstructive pulmonary disease	0.000684	0.00278	CcSEcCtD
Dextropropoxyphene—Loss of consciousness—Salbutamol—chronic obstructive pulmonary disease	0.000675	0.00274	CcSEcCtD
Dextropropoxyphene—Gastrointestinal pain—Tiotropium—chronic obstructive pulmonary disease	0.000673	0.00273	CcSEcCtD
Dextropropoxyphene—Toremifene—CYP1A1—chronic obstructive pulmonary disease	0.000671	0.0996	CrCbGaD
Dextropropoxyphene—Nervous system disorder—Arformoterol—chronic obstructive pulmonary disease	0.000651	0.00264	CcSEcCtD
Dextropropoxyphene—Nervous system disorder—Formoterol—chronic obstructive pulmonary disease	0.000651	0.00264	CcSEcCtD
Dextropropoxyphene—Abdominal pain—Tiotropium—chronic obstructive pulmonary disease	0.00065	0.00264	CcSEcCtD
Dextropropoxyphene—Tachycardia—Arformoterol—chronic obstructive pulmonary disease	0.000648	0.00263	CcSEcCtD
Dextropropoxyphene—Tachycardia—Formoterol—chronic obstructive pulmonary disease	0.000648	0.00263	CcSEcCtD
Dextropropoxyphene—Toremifene—CYP1A2—chronic obstructive pulmonary disease	0.000647	0.0961	CrCbGaD
Dextropropoxyphene—Discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000646	0.00262	CcSEcCtD
Dextropropoxyphene—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.000643	0.00261	CcSEcCtD
Dextropropoxyphene—Nervous system disorder—Montelukast—chronic obstructive pulmonary disease	0.000638	0.00259	CcSEcCtD
Dextropropoxyphene—Euphoric mood—Prednisone—chronic obstructive pulmonary disease	0.000629	0.00255	CcSEcCtD
Dextropropoxyphene—Hypotension—Arformoterol—chronic obstructive pulmonary disease	0.00062	0.00252	CcSEcCtD
Dextropropoxyphene—Hypotension—Formoterol—chronic obstructive pulmonary disease	0.00062	0.00252	CcSEcCtD
Dextropropoxyphene—Shock—Salbutamol—chronic obstructive pulmonary disease	0.000617	0.0025	CcSEcCtD
Dextropropoxyphene—Nervous system disorder—Salbutamol—chronic obstructive pulmonary disease	0.000615	0.00249	CcSEcCtD
Dextropropoxyphene—Tachycardia—Salbutamol—chronic obstructive pulmonary disease	0.000612	0.00248	CcSEcCtD
Dextropropoxyphene—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.000606	0.00246	CcSEcCtD
Dextropropoxyphene—Insomnia—Formoterol—chronic obstructive pulmonary disease	0.000601	0.00244	CcSEcCtD
Dextropropoxyphene—Insomnia—Arformoterol—chronic obstructive pulmonary disease	0.000601	0.00244	CcSEcCtD
Dextropropoxyphene—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.000597	0.00242	CcSEcCtD
Dextropropoxyphene—Dyspnoea—Formoterol—chronic obstructive pulmonary disease	0.000592	0.0024	CcSEcCtD
Dextropropoxyphene—Dyspnoea—Arformoterol—chronic obstructive pulmonary disease	0.000592	0.0024	CcSEcCtD
Dextropropoxyphene—Somnolence—Arformoterol—chronic obstructive pulmonary disease	0.00059	0.00239	CcSEcCtD
Dextropropoxyphene—Somnolence—Formoterol—chronic obstructive pulmonary disease	0.00059	0.00239	CcSEcCtD
Dextropropoxyphene—Insomnia—Montelukast—chronic obstructive pulmonary disease	0.000588	0.00239	CcSEcCtD
Dextropropoxyphene—Cardiac failure congestive—Prednisone—chronic obstructive pulmonary disease	0.000586	0.00238	CcSEcCtD
Dextropropoxyphene—Hypotension—Salbutamol—chronic obstructive pulmonary disease	0.000586	0.00238	CcSEcCtD
Dextropropoxyphene—Dyspepsia—Arformoterol—chronic obstructive pulmonary disease	0.000584	0.00237	CcSEcCtD
Dextropropoxyphene—Dyspepsia—Formoterol—chronic obstructive pulmonary disease	0.000584	0.00237	CcSEcCtD
Dextropropoxyphene—Somnolence—Montelukast—chronic obstructive pulmonary disease	0.000578	0.00235	CcSEcCtD
Dextropropoxyphene—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.000577	0.00234	CcSEcCtD
Dextropropoxyphene—Gastrointestinal disorder—Formoterol—chronic obstructive pulmonary disease	0.000573	0.00233	CcSEcCtD
Dextropropoxyphene—Gastrointestinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.000573	0.00233	CcSEcCtD
Dextropropoxyphene—Dyspepsia—Montelukast—chronic obstructive pulmonary disease	0.000572	0.00232	CcSEcCtD
Dextropropoxyphene—Constipation—Formoterol—chronic obstructive pulmonary disease	0.000568	0.0023	CcSEcCtD
Dextropropoxyphene—Constipation—Arformoterol—chronic obstructive pulmonary disease	0.000568	0.0023	CcSEcCtD
Dextropropoxyphene—Insomnia—Salbutamol—chronic obstructive pulmonary disease	0.000567	0.0023	CcSEcCtD
Dextropropoxyphene—Gastrointestinal disorder—Montelukast—chronic obstructive pulmonary disease	0.000561	0.00228	CcSEcCtD
Dextropropoxyphene—Dyspnoea—Salbutamol—chronic obstructive pulmonary disease	0.000559	0.00227	CcSEcCtD
Dextropropoxyphene—Somnolence—Salbutamol—chronic obstructive pulmonary disease	0.000557	0.00226	CcSEcCtD
Dextropropoxyphene—Acute coronary syndrome—Prednisolone—chronic obstructive pulmonary disease	0.000556	0.00225	CcSEcCtD
Dextropropoxyphene—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.000555	0.00225	CcSEcCtD
Dextropropoxyphene—Myocardial infarction—Prednisolone—chronic obstructive pulmonary disease	0.000553	0.00224	CcSEcCtD
Dextropropoxyphene—Dyspepsia—Salbutamol—chronic obstructive pulmonary disease	0.000552	0.00224	CcSEcCtD
Dextropropoxyphene—Rash—Aminophylline—chronic obstructive pulmonary disease	0.00055	0.00223	CcSEcCtD
Dextropropoxyphene—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.00055	0.00223	CcSEcCtD
Dextropropoxyphene—Feeling abnormal—Formoterol—chronic obstructive pulmonary disease	0.000547	0.00222	CcSEcCtD
Dextropropoxyphene—Feeling abnormal—Arformoterol—chronic obstructive pulmonary disease	0.000547	0.00222	CcSEcCtD
Dextropropoxyphene—Headache—Aminophylline—chronic obstructive pulmonary disease	0.000547	0.00222	CcSEcCtD
Dextropropoxyphene—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.000544	0.00221	CcSEcCtD
Dextropropoxyphene—Gastrointestinal pain—Formoterol—chronic obstructive pulmonary disease	0.000543	0.0022	CcSEcCtD
Dextropropoxyphene—Gastrointestinal pain—Arformoterol—chronic obstructive pulmonary disease	0.000543	0.0022	CcSEcCtD
Dextropropoxyphene—Gastrointestinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.000541	0.0022	CcSEcCtD
Dextropropoxyphene—Constipation—Salbutamol—chronic obstructive pulmonary disease	0.000536	0.00217	CcSEcCtD
Dextropropoxyphene—Gastrointestinal pain—Montelukast—chronic obstructive pulmonary disease	0.000532	0.00216	CcSEcCtD
Dextropropoxyphene—Gastrointestinal haemorrhage—Prednisone—chronic obstructive pulmonary disease	0.000532	0.00216	CcSEcCtD
Dextropropoxyphene—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	0.000525	0.00213	CcSEcCtD
Dextropropoxyphene—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	0.000525	0.00213	CcSEcCtD
Dextropropoxyphene—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.000523	0.00212	CcSEcCtD
Dextropropoxyphene—Psychotic disorder—Prednisone—chronic obstructive pulmonary disease	0.000519	0.00211	CcSEcCtD
Dextropropoxyphene—Rash—Tiotropium—chronic obstructive pulmonary disease	0.000519	0.0021	CcSEcCtD
Dextropropoxyphene—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.000518	0.0021	CcSEcCtD
Dextropropoxyphene—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.000518	0.0021	CcSEcCtD
Dextropropoxyphene—Feeling abnormal—Salbutamol—chronic obstructive pulmonary disease	0.000517	0.0021	CcSEcCtD
Dextropropoxyphene—Headache—Tiotropium—chronic obstructive pulmonary disease	0.000515	0.00209	CcSEcCtD
Dextropropoxyphene—Bradycardia—Prednisolone—chronic obstructive pulmonary disease	0.000515	0.00209	CcSEcCtD
Dextropropoxyphene—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	0.000514	0.00209	CcSEcCtD
Dextropropoxyphene—Gastrointestinal pain—Salbutamol—chronic obstructive pulmonary disease	0.000513	0.00208	CcSEcCtD
Dextropropoxyphene—Cardiac arrest—Prednisone—chronic obstructive pulmonary disease	0.000506	0.00205	CcSEcCtD
Dextropropoxyphene—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	0.000496	0.00201	CcSEcCtD
Dextropropoxyphene—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	0.000489	0.00198	CcSEcCtD
Dextropropoxyphene—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	0.000489	0.00198	CcSEcCtD
Dextropropoxyphene—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.000489	0.00198	CcSEcCtD
Dextropropoxyphene—Visual impairment—Prednisolone—chronic obstructive pulmonary disease	0.000488	0.00198	CcSEcCtD
Dextropropoxyphene—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	0.000479	0.00194	CcSEcCtD
Dextropropoxyphene—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.000476	0.00193	CcSEcCtD
Dextropropoxyphene—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.000476	0.00193	CcSEcCtD
Dextropropoxyphene—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.000467	0.00189	CcSEcCtD
Dextropropoxyphene—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	0.000462	0.00187	CcSEcCtD
Dextropropoxyphene—Propafenone—CYP1A2—chronic obstructive pulmonary disease	0.000456	0.0677	CrCbGaD
Dextropropoxyphene—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.000454	0.00184	CcSEcCtD
Dextropropoxyphene—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.000454	0.00184	CcSEcCtD
Dextropropoxyphene—Arrhythmia—Prednisolone—chronic obstructive pulmonary disease	0.000452	0.00183	CcSEcCtD
Dextropropoxyphene—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.00045	0.00182	CcSEcCtD
Dextropropoxyphene—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.000445	0.0018	CcSEcCtD
Dextropropoxyphene—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.000439	0.00178	CcSEcCtD
Dextropropoxyphene—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.000439	0.00178	CcSEcCtD
Dextropropoxyphene—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.00043	0.00174	CcSEcCtD
Dextropropoxyphene—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.000429	0.00174	CcSEcCtD
Dextropropoxyphene—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.000422	0.00171	CcSEcCtD
Dextropropoxyphene—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.000422	0.00171	CcSEcCtD
Dextropropoxyphene—Rash—Formoterol—chronic obstructive pulmonary disease	0.000419	0.0017	CcSEcCtD
Dextropropoxyphene—Rash—Arformoterol—chronic obstructive pulmonary disease	0.000419	0.0017	CcSEcCtD
Dextropropoxyphene—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.000418	0.0017	CcSEcCtD
Dextropropoxyphene—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.000418	0.0017	CcSEcCtD
Dextropropoxyphene—Headache—Formoterol—chronic obstructive pulmonary disease	0.000416	0.00169	CcSEcCtD
Dextropropoxyphene—Headache—Arformoterol—chronic obstructive pulmonary disease	0.000416	0.00169	CcSEcCtD
Dextropropoxyphene—Vision blurred—Prednisolone—chronic obstructive pulmonary disease	0.000415	0.00168	CcSEcCtD
Dextropropoxyphene—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.000415	0.00168	CcSEcCtD
Dextropropoxyphene—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.000414	0.00168	CcSEcCtD
Dextropropoxyphene—Rash—Montelukast—chronic obstructive pulmonary disease	0.00041	0.00166	CcSEcCtD
Dextropropoxyphene—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.00041	0.00166	CcSEcCtD
Dextropropoxyphene—Headache—Montelukast—chronic obstructive pulmonary disease	0.000407	0.00165	CcSEcCtD
Dextropropoxyphene—Acute coronary syndrome—Prednisone—chronic obstructive pulmonary disease	0.000404	0.00164	CcSEcCtD
Dextropropoxyphene—Myocardial infarction—Prednisone—chronic obstructive pulmonary disease	0.000402	0.00163	CcSEcCtD
Dextropropoxyphene—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.000399	0.00162	CcSEcCtD
Dextropropoxyphene—Rash—Salbutamol—chronic obstructive pulmonary disease	0.000395	0.0016	CcSEcCtD
Dextropropoxyphene—Syncope—Prednisolone—chronic obstructive pulmonary disease	0.000395	0.0016	CcSEcCtD
Dextropropoxyphene—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.000395	0.0016	CcSEcCtD
Dextropropoxyphene—Nausea—Formoterol—chronic obstructive pulmonary disease	0.000394	0.0016	CcSEcCtD
Dextropropoxyphene—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.000394	0.0016	CcSEcCtD
Dextropropoxyphene—Headache—Salbutamol—chronic obstructive pulmonary disease	0.000393	0.00159	CcSEcCtD
Dextropropoxyphene—Loss of consciousness—Prednisolone—chronic obstructive pulmonary disease	0.000387	0.00157	CcSEcCtD
Dextropropoxyphene—Nausea—Montelukast—chronic obstructive pulmonary disease	0.000386	0.00157	CcSEcCtD
Dextropropoxyphene—Phenoxybenzamine—ADRB2—chronic obstructive pulmonary disease	0.000383	0.0568	CrCbGaD
Dextropropoxyphene—Modafinil—CYP1A2—chronic obstructive pulmonary disease	0.000382	0.0567	CrCbGaD
Dextropropoxyphene—Convulsion—Prednisolone—chronic obstructive pulmonary disease	0.000382	0.00155	CcSEcCtD
Dextropropoxyphene—Bradycardia—Prednisone—chronic obstructive pulmonary disease	0.000374	0.00152	CcSEcCtD
Dextropropoxyphene—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.000372	0.00151	CcSEcCtD
Dextropropoxyphene—Discomfort—Prednisolone—chronic obstructive pulmonary disease	0.000371	0.0015	CcSEcCtD
Dextropropoxyphene—Hallucination—Prednisone—chronic obstructive pulmonary disease	0.000366	0.00148	CcSEcCtD
Dextropropoxyphene—Shock—Prednisolone—chronic obstructive pulmonary disease	0.000354	0.00143	CcSEcCtD
Dextropropoxyphene—Tachycardia—Prednisolone—chronic obstructive pulmonary disease	0.000351	0.00142	CcSEcCtD
Dextropropoxyphene—Eye disorder—Prednisone—chronic obstructive pulmonary disease	0.000344	0.00139	CcSEcCtD
Dextropropoxyphene—Immune system disorder—Prednisone—chronic obstructive pulmonary disease	0.000332	0.00135	CcSEcCtD
Dextropropoxyphene—Arrhythmia—Prednisone—chronic obstructive pulmonary disease	0.000329	0.00133	CcSEcCtD
Dextropropoxyphene—Insomnia—Prednisolone—chronic obstructive pulmonary disease	0.000325	0.00132	CcSEcCtD
Dextropropoxyphene—Malnutrition—Prednisone—chronic obstructive pulmonary disease	0.00032	0.0013	CcSEcCtD
Dextropropoxyphene—Vision blurred—Prednisone—chronic obstructive pulmonary disease	0.000302	0.00122	CcSEcCtD
Dextropropoxyphene—Trimipramine—SLC6A4—chronic obstructive pulmonary disease	0.000297	0.0441	CrCbGaD
Dextropropoxyphene—Feeling abnormal—Prednisolone—chronic obstructive pulmonary disease	0.000296	0.0012	CcSEcCtD
Dextropropoxyphene—Agitation—Prednisone—chronic obstructive pulmonary disease	0.000294	0.00119	CcSEcCtD
Dextropropoxyphene—Syncope—Prednisone—chronic obstructive pulmonary disease	0.000287	0.00116	CcSEcCtD
Dextropropoxyphene—Loss of consciousness—Prednisone—chronic obstructive pulmonary disease	0.000281	0.00114	CcSEcCtD
Dextropropoxyphene—Convulsion—Prednisone—chronic obstructive pulmonary disease	0.000277	0.00113	CcSEcCtD
Dextropropoxyphene—Discomfort—Prednisone—chronic obstructive pulmonary disease	0.000269	0.00109	CcSEcCtD
Dextropropoxyphene—Tamoxifen—CYP1A1—chronic obstructive pulmonary disease	0.000268	0.0398	CrCbGaD
Dextropropoxyphene—Diphenhydramine—CYP1A2—chronic obstructive pulmonary disease	0.000265	0.0394	CrCbGaD
Dextropropoxyphene—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	0.000265	0.00107	CcSEcCtD
Dextropropoxyphene—Tamoxifen—CYP1A2—chronic obstructive pulmonary disease	0.000258	0.0384	CrCbGaD
Dextropropoxyphene—Shock—Prednisone—chronic obstructive pulmonary disease	0.000257	0.00104	CcSEcCtD
Dextropropoxyphene—Nervous system disorder—Prednisone—chronic obstructive pulmonary disease	0.000256	0.00104	CcSEcCtD
Dextropropoxyphene—Methadone—CYP1A2—chronic obstructive pulmonary disease	0.000256	0.038	CrCbGaD
Dextropropoxyphene—Tachycardia—Prednisone—chronic obstructive pulmonary disease	0.000255	0.00103	CcSEcCtD
Dextropropoxyphene—Dizziness—Prednisolone—chronic obstructive pulmonary disease	0.000238	0.000964	CcSEcCtD
Dextropropoxyphene—Insomnia—Prednisone—chronic obstructive pulmonary disease	0.000236	0.000959	CcSEcCtD
Dextropropoxyphene—Dyspepsia—Prednisone—chronic obstructive pulmonary disease	0.00023	0.000933	CcSEcCtD
Dextropropoxyphene—Trimipramine—HTR2A—chronic obstructive pulmonary disease	0.000228	0.0339	CrCbGaD
Dextropropoxyphene—Rash—Prednisolone—chronic obstructive pulmonary disease	0.000227	0.00092	CcSEcCtD
Dextropropoxyphene—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	0.000227	0.000919	CcSEcCtD
Dextropropoxyphene—Headache—Prednisolone—chronic obstructive pulmonary disease	0.000225	0.000914	CcSEcCtD
Dextropropoxyphene—Constipation—Prednisone—chronic obstructive pulmonary disease	0.000223	0.000906	CcSEcCtD
Dextropropoxyphene—Feeling abnormal—Prednisone—chronic obstructive pulmonary disease	0.000215	0.000873	CcSEcCtD
Dextropropoxyphene—Gastrointestinal pain—Prednisone—chronic obstructive pulmonary disease	0.000214	0.000867	CcSEcCtD
Dextropropoxyphene—Nausea—Prednisolone—chronic obstructive pulmonary disease	0.000214	0.000866	CcSEcCtD
Dextropropoxyphene—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	0.000207	0.000838	CcSEcCtD
Dextropropoxyphene—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	0.000193	0.000781	CcSEcCtD
Dextropropoxyphene—Asthenia—Prednisone—chronic obstructive pulmonary disease	0.000187	0.00076	CcSEcCtD
Dextropropoxyphene—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	0.000179	0.000725	CcSEcCtD
Dextropropoxyphene—Dizziness—Prednisone—chronic obstructive pulmonary disease	0.000173	0.000701	CcSEcCtD
Dextropropoxyphene—Vomiting—Prednisone—chronic obstructive pulmonary disease	0.000166	0.000674	CcSEcCtD
Dextropropoxyphene—Rash—Prednisone—chronic obstructive pulmonary disease	0.000165	0.000668	CcSEcCtD
Dextropropoxyphene—Dermatitis—Prednisone—chronic obstructive pulmonary disease	0.000165	0.000668	CcSEcCtD
Dextropropoxyphene—Headache—Prednisone—chronic obstructive pulmonary disease	0.000164	0.000664	CcSEcCtD
Dextropropoxyphene—Nausea—Prednisone—chronic obstructive pulmonary disease	0.000155	0.00063	CcSEcCtD
Dextropropoxyphene—OPRD1—Class A/1 (Rhodopsin-like receptors)—HTR2A—chronic obstructive pulmonary disease	0.000126	0.00192	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling by GPCR—PDE4A—chronic obstructive pulmonary disease	0.000125	0.00189	CbGpPWpGaD
Dextropropoxyphene—OPRD1—GPCR ligand binding—ADRB2—chronic obstructive pulmonary disease	0.000123	0.00187	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.000121	0.00184	CbGpPWpGaD
Dextropropoxyphene—OPRK1—GPCR downstream signaling—PDE4A—chronic obstructive pulmonary disease	0.00012	0.00183	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	0.00012	0.00182	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Class A/1 (Rhodopsin-like receptors)—ADRB2—chronic obstructive pulmonary disease	0.00012	0.00182	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—FAM13A—chronic obstructive pulmonary disease	0.000119	0.00181	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	0.000118	0.0018	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	0.000118	0.00179	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	0.000117	0.00178	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Biological oxidations—GCLC—chronic obstructive pulmonary disease	0.000117	0.00178	CbGpPWpGaD
Dextropropoxyphene—OPRM1—TCR Signaling Pathway—TGFB1—chronic obstructive pulmonary disease	0.000117	0.00177	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Peptide ligand-binding receptors—CXCL8—chronic obstructive pulmonary disease	0.000116	0.00176	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Biological oxidations—GCLC—chronic obstructive pulmonary disease	0.000116	0.00176	CbGpPWpGaD
Dextropropoxyphene—CYP3A7—Metabolism—APIP—chronic obstructive pulmonary disease	0.000112	0.0017	CbGpPWpGaD
Dextropropoxyphene—OPRD1—GPCR downstream signaling—CXCR2—chronic obstructive pulmonary disease	0.000111	0.00168	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Class A/1 (Rhodopsin-like receptors)—HTR2A—chronic obstructive pulmonary disease	0.000111	0.00168	CbGpPWpGaD
Dextropropoxyphene—OPRD1—GPCR ligand binding—EDN1—chronic obstructive pulmonary disease	0.00011	0.00167	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling by GPCR—PDE4A—chronic obstructive pulmonary disease	0.000109	0.00166	CbGpPWpGaD
Dextropropoxyphene—OPRM1—GPCRs, Class A Rhodopsin-like—HTR2A—chronic obstructive pulmonary disease	0.000109	0.00166	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	0.000108	0.00165	CbGpPWpGaD
Dextropropoxyphene—OPRK1—GPCR ligand binding—ADRB2—chronic obstructive pulmonary disease	0.000108	0.00164	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	0.000107	0.00163	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Class A/1 (Rhodopsin-like receptors)—EDN1—chronic obstructive pulmonary disease	0.000107	0.00162	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Peptide ligand-binding receptors—CXCL8—chronic obstructive pulmonary disease	0.000102	0.00155	CbGpPWpGaD
Dextropropoxyphene—OPRM1—GPCR downstream signaling—PDE4A—chronic obstructive pulmonary disease	0.000102	0.00155	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	0.000101	0.00154	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling by GPCR—CXCR2—chronic obstructive pulmonary disease	0.000101	0.00153	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	9.99e-05	0.00152	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	9.85e-05	0.0015	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	9.83e-05	0.00149	CbGpPWpGaD
Dextropropoxyphene—OPRD1—G alpha (i) signalling events—CXCL8—chronic obstructive pulmonary disease	9.8e-05	0.00149	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	9.75e-05	0.00148	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	9.72e-05	0.00148	CbGpPWpGaD
Dextropropoxyphene—OPRK1—GPCR downstream signaling—CXCR2—chronic obstructive pulmonary disease	9.7e-05	0.00147	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	9.7e-05	0.00147	CbGpPWpGaD
Dextropropoxyphene—OPRK1—GPCR ligand binding—EDN1—chronic obstructive pulmonary disease	9.63e-05	0.00146	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	9.62e-05	0.00146	CbGpPWpGaD
Dextropropoxyphene—OPRD1—GPCR ligand binding—HTR2A—chronic obstructive pulmonary disease	9.6e-05	0.00146	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Class A/1 (Rhodopsin-like receptors)—HTR2A—chronic obstructive pulmonary disease	9.35e-05	0.00142	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling by GPCR—PDE4A—chronic obstructive pulmonary disease	9.24e-05	0.0014	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	9.18e-05	0.00139	CbGpPWpGaD
Dextropropoxyphene—OPRM1—GPCR ligand binding—ADRB2—chronic obstructive pulmonary disease	9.1e-05	0.00138	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	9.06e-05	0.00137	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling by GPCR—CXCR2—chronic obstructive pulmonary disease	8.81e-05	0.00134	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	8.79e-05	0.00134	CbGpPWpGaD
Dextropropoxyphene—OPRM1—TCR Signaling Pathway—IL6—chronic obstructive pulmonary disease	8.79e-05	0.00134	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	8.7e-05	0.00132	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Peptide ligand-binding receptors—CXCL8—chronic obstructive pulmonary disease	8.61e-05	0.00131	CbGpPWpGaD
Dextropropoxyphene—OPRK1—G alpha (i) signalling events—CXCL8—chronic obstructive pulmonary disease	8.59e-05	0.0013	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	8.58e-05	0.0013	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	8.52e-05	0.00129	CbGpPWpGaD
Dextropropoxyphene—OPRK1—GPCR ligand binding—HTR2A—chronic obstructive pulmonary disease	8.42e-05	0.00128	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	8.25e-05	0.00125	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	8.2e-05	0.00125	CbGpPWpGaD
Dextropropoxyphene—OPRM1—GPCR downstream signaling—CXCR2—chronic obstructive pulmonary disease	8.2e-05	0.00125	CbGpPWpGaD
Dextropropoxyphene—OPRM1—GPCR ligand binding—EDN1—chronic obstructive pulmonary disease	8.14e-05	0.00124	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	8.13e-05	0.00123	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	8.09e-05	0.00123	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	8.02e-05	0.00122	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	7.79e-05	0.00118	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	7.74e-05	0.00117	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Biological oxidations—GCLC—chronic obstructive pulmonary disease	7.65e-05	0.00116	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	7.54e-05	0.00114	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	7.47e-05	0.00113	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling by GPCR—CXCR2—chronic obstructive pulmonary disease	7.45e-05	0.00113	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	7.43e-05	0.00113	CbGpPWpGaD
Dextropropoxyphene—CYP3A7—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	7.41e-05	0.00112	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	7.37e-05	0.00112	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	7.37e-05	0.00112	CbGpPWpGaD
Dextropropoxyphene—OPRM1—G alpha (i) signalling events—CXCL8—chronic obstructive pulmonary disease	7.26e-05	0.0011	CbGpPWpGaD
Dextropropoxyphene—CYP3A7—Metabolism—GC—chronic obstructive pulmonary disease	7.21e-05	0.00109	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	7.2e-05	0.00109	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	7.15e-05	0.00109	CbGpPWpGaD
Dextropropoxyphene—OPRM1—GPCR ligand binding—HTR2A—chronic obstructive pulmonary disease	7.12e-05	0.00108	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	7.08e-05	0.00108	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	7.05e-05	0.00107	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Metabolism—APIP—chronic obstructive pulmonary disease	7e-05	0.00106	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	6.99e-05	0.00106	CbGpPWpGaD
Dextropropoxyphene—OPRD1—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	6.94e-05	0.00105	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	6.83e-05	0.00104	CbGpPWpGaD
Dextropropoxyphene—CYP3A7—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	6.7e-05	0.00102	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	6.46e-05	0.000981	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	6.43e-05	0.000976	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	6.34e-05	0.000963	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	6.3e-05	0.000957	CbGpPWpGaD
Dextropropoxyphene—OPRD1—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	6.2e-05	0.000942	CbGpPWpGaD
Dextropropoxyphene—OPRK1—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	6.09e-05	0.000924	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	5.94e-05	0.000902	CbGpPWpGaD
Dextropropoxyphene—OPRD1—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	5.93e-05	0.000901	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	5.77e-05	0.000877	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Metabolism—APIP—chronic obstructive pulmonary disease	5.75e-05	0.000873	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism—APIP—chronic obstructive pulmonary disease	5.7e-05	0.000865	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	5.63e-05	0.000856	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	5.53e-05	0.000839	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	5.46e-05	0.000829	CbGpPWpGaD
Dextropropoxyphene—OPRK1—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	5.44e-05	0.000826	CbGpPWpGaD
Dextropropoxyphene—OPRD1—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	5.43e-05	0.000824	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	5.36e-05	0.000814	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	5.29e-05	0.000803	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	5.21e-05	0.000791	CbGpPWpGaD
Dextropropoxyphene—OPRK1—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	5.2e-05	0.00079	CbGpPWpGaD
Dextropropoxyphene—OPRM1—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	5.15e-05	0.000781	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	4.99e-05	0.000758	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	4.94e-05	0.00075	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	4.93e-05	0.000748	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	4.93e-05	0.000748	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	4.86e-05	0.000738	CbGpPWpGaD
Dextropropoxyphene—OPRK1—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	4.76e-05	0.000723	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	4.67e-05	0.00071	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	4.67e-05	0.000709	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	4.64e-05	0.000704	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	4.61e-05	0.0007	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	4.6e-05	0.000698	CbGpPWpGaD
Dextropropoxyphene—OPRM1—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	4.6e-05	0.000698	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Metabolism—GC—chronic obstructive pulmonary disease	4.51e-05	0.000685	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	4.4e-05	0.000668	CbGpPWpGaD
Dextropropoxyphene—OPRM1—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	4.4e-05	0.000668	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	4.34e-05	0.000659	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	4.32e-05	0.000656	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	4.19e-05	0.000637	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	4.18e-05	0.000634	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	4.06e-05	0.000617	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—KL—chronic obstructive pulmonary disease	4.04e-05	0.000613	CbGpPWpGaD
Dextropropoxyphene—OPRM1—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	4.02e-05	0.000611	CbGpPWpGaD
Dextropropoxyphene—CYP3A7—Metabolism—GSTT1—chronic obstructive pulmonary disease	3.94e-05	0.000598	CbGpPWpGaD
Dextropropoxyphene—CYP3A7—Metabolism—GCLC—chronic obstructive pulmonary disease	3.89e-05	0.000591	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	3.81e-05	0.000578	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	3.81e-05	0.000578	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	3.78e-05	0.000573	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—APIP—chronic obstructive pulmonary disease	3.76e-05	0.000571	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	3.74e-05	0.000568	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	3.72e-05	0.000566	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Metabolism—GC—chronic obstructive pulmonary disease	3.7e-05	0.000562	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism—GC—chronic obstructive pulmonary disease	3.67e-05	0.000558	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	3.65e-05	0.000555	CbGpPWpGaD
Dextropropoxyphene—CYP3A7—Metabolism—CTGF—chronic obstructive pulmonary disease	3.55e-05	0.000539	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—KL—chronic obstructive pulmonary disease	3.54e-05	0.000537	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	3.44e-05	0.000523	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	3.41e-05	0.000518	CbGpPWpGaD
Dextropropoxyphene—OPRD1—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	3.35e-05	0.000509	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	3.34e-05	0.000508	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	3.33e-05	0.000505	CbGpPWpGaD
Dextropropoxyphene—CYP3A7—Metabolism—CYP1A2—chronic obstructive pulmonary disease	3.27e-05	0.000497	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	3.27e-05	0.000496	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	3.22e-05	0.000489	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	3.05e-05	0.000462	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	3.03e-05	0.000459	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—KL—chronic obstructive pulmonary disease	2.99e-05	0.000454	CbGpPWpGaD
Dextropropoxyphene—OPRK1—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	2.94e-05	0.000446	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	2.92e-05	0.000443	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	2.91e-05	0.000442	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	2.76e-05	0.000419	CbGpPWpGaD
Dextropropoxyphene—CYP3A7—Metabolism—GSTP1—chronic obstructive pulmonary disease	2.73e-05	0.000414	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	2.72e-05	0.000413	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—LEP—chronic obstructive pulmonary disease	2.71e-05	0.000411	CbGpPWpGaD
Dextropropoxyphene—CYP3A7—Metabolism—HMOX1—chronic obstructive pulmonary disease	2.69e-05	0.000409	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	2.67e-05	0.000405	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	2.65e-05	0.000403	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	2.55e-05	0.000388	CbGpPWpGaD
Dextropropoxyphene—CYP3A7—Metabolism—GSTM1—chronic obstructive pulmonary disease	2.51e-05	0.000381	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	2.49e-05	0.000378	CbGpPWpGaD
Dextropropoxyphene—OPRM1—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	2.49e-05	0.000377	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	2.47e-05	0.000375	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Metabolism—GSTT1—chronic obstructive pulmonary disease	2.47e-05	0.000374	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Metabolism—GCLC—chronic obstructive pulmonary disease	2.44e-05	0.00037	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—GC—chronic obstructive pulmonary disease	2.42e-05	0.000368	CbGpPWpGaD
Dextropropoxyphene—CYP3A7—Metabolism—CYP1A1—chronic obstructive pulmonary disease	2.38e-05	0.000361	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—LEP—chronic obstructive pulmonary disease	2.37e-05	0.00036	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	2.27e-05	0.000345	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	2.26e-05	0.000343	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	2.25e-05	0.000342	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	2.24e-05	0.00034	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	2.23e-05	0.000338	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Metabolism—CTGF—chronic obstructive pulmonary disease	2.22e-05	0.000338	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	2.16e-05	0.000328	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	2.12e-05	0.000323	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Metabolism—CYP1A2—chronic obstructive pulmonary disease	2.05e-05	0.000311	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	2.03e-05	0.000308	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Metabolism—GSTT1—chronic obstructive pulmonary disease	2.02e-05	0.000307	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism—GSTT1—chronic obstructive pulmonary disease	2.01e-05	0.000305	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—LEP—chronic obstructive pulmonary disease	2.01e-05	0.000305	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Metabolism—GCLC—chronic obstructive pulmonary disease	2e-05	0.000304	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism—GCLC—chronic obstructive pulmonary disease	1.98e-05	0.000301	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	1.95e-05	0.000296	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	1.86e-05	0.000283	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	1.85e-05	0.000281	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Metabolism—CTGF—chronic obstructive pulmonary disease	1.83e-05	0.000277	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism—CTGF—chronic obstructive pulmonary disease	1.81e-05	0.000275	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	1.8e-05	0.000273	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	1.78e-05	0.00027	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	1.71e-05	0.00026	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.71e-05	0.000259	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.69e-05	0.000256	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.68e-05	0.000255	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.67e-05	0.000253	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	1.65e-05	0.00025	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	1.63e-05	0.000247	CbGpPWpGaD
Dextropropoxyphene—CYP3A7—Metabolism—ALB—chronic obstructive pulmonary disease	1.62e-05	0.000245	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	1.58e-05	0.00024	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	1.57e-05	0.000239	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.57e-05	0.000238	CbGpPWpGaD
Dextropropoxyphene—CYP3A7—Metabolism—NOS3—chronic obstructive pulmonary disease	1.55e-05	0.000235	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	1.5e-05	0.000228	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	1.5e-05	0.000228	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.49e-05	0.000226	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	1.46e-05	0.000222	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	1.43e-05	0.000217	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.4e-05	0.000213	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.39e-05	0.000211	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.38e-05	0.00021	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.37e-05	0.000208	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	1.34e-05	0.000204	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	1.33e-05	0.000202	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.32e-05	0.000201	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	1.31e-05	0.0002	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—GCLC—chronic obstructive pulmonary disease	1.31e-05	0.000199	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.29e-05	0.000196	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	1.28e-05	0.000195	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.28e-05	0.000194	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	1.27e-05	0.000192	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.22e-05	0.000186	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.21e-05	0.000184	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	1.21e-05	0.000183	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—CTGF—chronic obstructive pulmonary disease	1.19e-05	0.000181	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	1.18e-05	0.000179	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	1.15e-05	0.000175	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—TP53—chronic obstructive pulmonary disease	1.1e-05	0.000168	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.1e-05	0.000167	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	1.08e-05	0.000164	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Metabolism—ALB—chronic obstructive pulmonary disease	1.01e-05	0.000154	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—IL6—chronic obstructive pulmonary disease	1.01e-05	0.000153	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	9.94e-06	0.000151	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	9.74e-06	0.000148	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—TP53—chronic obstructive pulmonary disease	9.68e-06	0.000147	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Metabolism—NOS3—chronic obstructive pulmonary disease	9.68e-06	0.000147	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—GSTP1—chronic obstructive pulmonary disease	9.17e-06	0.000139	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—HMOX1—chronic obstructive pulmonary disease	9.04e-06	0.000137	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—IL6—chronic obstructive pulmonary disease	8.86e-06	0.000135	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—GSTM1—chronic obstructive pulmonary disease	8.43e-06	0.000128	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Metabolism—ALB—chronic obstructive pulmonary disease	8.31e-06	0.000126	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism—ALB—chronic obstructive pulmonary disease	8.23e-06	0.000125	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—TP53—chronic obstructive pulmonary disease	8.18e-06	0.000124	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—CYP1A1—chronic obstructive pulmonary disease	7.99e-06	0.000121	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Metabolism—NOS3—chronic obstructive pulmonary disease	7.95e-06	0.000121	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism—NOS3—chronic obstructive pulmonary disease	7.88e-06	0.00012	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—IL6—chronic obstructive pulmonary disease	7.49e-06	0.000114	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—ALB—chronic obstructive pulmonary disease	5.43e-06	8.25e-05	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—NOS3—chronic obstructive pulmonary disease	5.19e-06	7.89e-05	CbGpPWpGaD
